Author:
Voggenreiter Gregor,Assenmacher St.,Majetschak M.,Bardenheuer M.,Obertacke U.,Schade F. U.
Publisher
Springer Berlin Heidelberg
Reference5 articles.
1. Schade FU, Flach R, Flohé S, Majetschak M, Kreuzfelder E, Dominguez-Fernandez E, Börgermann J, Reuter, M, Obertacke U (1999) Endotoxin tolerance. In: Brade H, Opal SM, Vogel SN, Morrison DC (Hrsg). Endotoxin in health and disease. New York Basel: Marcel Dekker, Inc.; S. 751–767
2. Lader CS, Flanagan AM (1998) Prostaglandin E2, interleukin lalpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology 139: 3157–3164
3. Johnston C, Greisman S (1985) Mechanism of endotoxin tolerance. In: Hinshaw L (Hrsg). Handbook of endotoxin. Amsterdam New York Oxford: Elsevier, S. 359–391
4. Lindberg A, Greisman S, Svenson S (1983) Induction of endotoxin tolerance with non-pyrogenic Oantigenic oligosaccharide-protein conjugates. Infect Immun 41: 888–895
5. Sánchez-Cantú L, Rode HN, Christou NV (1989) Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 124: 1432 - 1436